About the ETNA Study
Learn what the study is about and what taking part may look like.
About the
ETNA Study
Learn what the study is about and what taking part may look like.
This research study is for adults living with generalized Myasthenia Gravis (gMG). The study is looking at an injectable investigational medication called povetacicept, which is given once every 4 weeks to help researchers learn more about its safety and tolerability.
In this study, some participants will receive the investigational medication, and others will receive a placebo. A placebo looks just like the investigational medication but does not contain active medicine. This helps researchers compare results across groups.
You May Be a Good Match for This Study If You:
Are between 18 and 80 years old
Have been diagnosed with generalized MG
Have one of the antibodies doctors look for in gMG
Have symptoms that affect daily activities
Are on a stable dose of your MG medications
Are between 18 and 80 years old
Have been diagnosed with generalized MG
Have one of the antibodies doctors look for in gMG
Have symptoms that affect daily activities
Are on a stable dose of your MG medications
Why This Study Matters for People With gMG
This study is being conducted to learn more about an investigational medication called povetacicept. Researchers want to understand whether it may help lower certain antibodies involved in gMG and evaluate how safe and tolerable it is for adults living with the condition.
The study will explore:
- How the investigational medicine may influence immune system activity
- How participants feel and function during everyday activities
- Changes in strength, fatigue, and overall activity levels over time
- Aspects of quality of life that are important to people living with gMG
Why This Study Matters for People With gMG
This study is being conducted to learn more about an investigational medication called povetacicept. Researchers want to understand whether it may help lower certain antibodies involved in gMG and evaluate how safe and tolerable it is for adults living with the condition.
The study will explore:
- How the investigational medicine may influence immune system activity
- How participants feel and function during everyday activities
- Changes in strength, fatigue, and overall activity levels over time
- Aspects of quality of life that are important to people living with gMG
Details About the Study
Study Phases
Before you can join the study, the team will take some time to learn about your health and see if the study is a good fit for you. During this step, you may be asked to:
- Share your medical history
- Talk about your current gMG treatments
- Have your gMG symptoms checked
- Give blood samples and complete other routine tests
This helps the team make sure the study is safe and appropriate for you.
Study treatment period
If you qualify for the study and decide to participate, you’ll have 12 weeks during the treatment period in which you’ll visit the study sites. At the site visits, your study doctor will:
- Check your vital signs and do a blood tests
- Ask about your symptoms and daily routine
- Talk with you about how you’re feeling overall
- Give you the study medication at no cost
Your study doctor may adjust or stop your study treatment if needed for your safety. And remember — you can leave the study at any time.
Optional long‑term extension period
If you finish the main study and qualify to continue, you may be able to join an optional long‑term extension, where you will receive the investigational medication for up to 96 weeks.
Why This Study Could Be a Good Fit
- Care that includes regular check‑ins, monitoring, and support
- An opportunity to help advance future treatment possibilities for gMG
- Participation in research focused on the underlying biology of the condition
Details About the Study
Study Phases
Before you can join the study, the team will take some time to learn about your health and see if the study is a good fit for you. During this step, you may be asked to:
- Share your medical history
- Talk about your current gMG treatments
- Have your gMG symptoms checked
- Give blood samples and complete other routine tests
This helps the team make sure the study is safe and appropriate for you.
Study treatment period
If you qualify for the study and decide to participate, you’ll have 12 weeks during the treatment period in which you’ll visit the study sites. At the site visits, your study doctor will:
- Check your vital signs and do a blood tests
- Ask about your symptoms and daily routine
- Talk with you about how you’re feeling overall
- Give you the study medication at no cost
Your study doctor may adjust or stop your study treatment if needed for your safety. And remember — you can leave the study at any time.
Optional long‑term extension period
If you finish the main study and qualify to continue, you may be able to join an optional long‑term extension, where you will receive the investigational medication for up to 96 weeks.
Why This Study Could Be a Good Fit
- Care that includes regular check‑ins, monitoring, and support
- An opportunity to help advance future treatment possibilities for gMG
- Participation in research focused on the underlying biology of the condition